Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
09:30 - 09:30 | Presenter: Hidehito Horinouchi | Author(s): M. Maemondo, T. Hida, M. Takeda, K. Hotta, F. Hirai, Y.H. Kim, S. Matsumoto, Tetsuya Mitsudomi, Takashi Seto, S. Moizumi, K. Tokushige, B. Hatano, Makoto Nishio
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park | Author(s): K. Azuma, C. Tsai, Takashi Seto, H. Nokihara, James Chih-Hsin Yang, Sang-We Kim, H. Murakami, Makoto Nishio, K. Kiura, A. Inoue, K. Takeda, Jin-Hyoung Kang, Hidetoshi Hayashi, T. Nakagawa, Y. Kaneko, R. Akazawa, M. Shimazaki, S. Morita, M. Fukuoka, Kazuhiko Nakagawa
- Abstract
Loading... -
+
OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)
17:00 - 17:10 | Presenter: Makoto Nishio | Author(s): K. Kiura, Takashi Seto, Kazuhiko Nakagawa, M. Maemondo, A. Inoue, T. Hida, H. Yoshioka, M. Harada, Yuichiro Ohe, N. Nogami, H. Murakami, K. Takeuchi, S. Inamura, H. Kuriki, T. Shimada, T. Tamura
- Abstract
Loading...
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-005 - GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC
09:30 - 09:30 | Presenter: Jürgen Wolf | Author(s): Ji-Youn Han, Makoto Nishio, P. Souquet, Luis Paz-Ares, F. De Marinis, Takashi Seto, M. De Jonge, T.M. Kim, Johan F. Vansteenkiste, Daniel SW Tan, Edward Brian Garon, H.J. Groen, Maximilian Johannes Hochmair, Enriqueta Felip, Noemi Reguart, M. Thomas, T.R. Overbeck, K. Ohashi, M. Giovannini, R. Yura, A. Joshi, M. Akimov, R. Heist
- Abstract
Loading...
-
+
GR 02 - Management of Immunotherapy-Related Adverse Events
- 11:00 - 12:30
- 10/17/2017
- Location: Main Hall
- Type: Grand Rounds
- Track: Immunology and Immunotherapy
- Moderators:Edward Brian Garon, Makoto Nishio
-
+
GR 02.00 - Intro
11:00 - 11:02 | Presenter: Makoto Nishio
- Abstract
No abstract available for this presentation
-
+
GR 02.01 - Case Study
11:02 - 11:07 | Presenter: Edward Brian Garon
- Abstract
No abstract available for this presentation
-
+
GR 02.02 - Case Study
11:07 - 11:12 | Presenter: Makoto Nishio
- Abstract
No abstract available for this presentation
-
+
GR 02.03 - Pathophysiology of Immunotherapy-related Toxicity
11:12 - 11:27 | Presenter: Ji-Youn Han
- Abstract
Loading... -
+
GR 02.04 - Current Standard in Monitoring of Immunotherapy-related Toxicity
11:27 - 11:42 | Presenter: Clarissa Mathias
- Abstract
Loading... -
+
GR 02.05 - Practical Management of Immunotherapy-related Toxicity
11:42 - 11:57 | Presenter: Scott N. Gettinger
- Abstract
No abstract available for this presentation
-
+
GR 02.06 - Who Should Not Receive Immunotherapy?
11:57 - 12:12 | Presenter: Terufumi Kato
- Abstract
No abstract available for this presentation
-
+
GR 02.07 - Toxicity of Induction Immunotherapy Followed by Radiotherapy: How to Minimize It?
12:12 - 12:27 | Presenter: Dirk K De Ruysscher
- Abstract
Loading... -
+
GR 02.08 - Q&A
12:27 - 12:32
- Abstract
No abstract available for this presentation
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
MA 12.02 - Phase I/II Study of S49076, a MET/AXL/FGFR Inhibitor, Combined with Gefitinib in NSCLC Patients Progressing on EGFR TKI
11:05 - 11:10 | Presenter: Gee-Chen Chang | Author(s): G. Curigliano, Wan-Teck Lim, S. Viteri, F. Ciardiello, T. Hida, Chia-Chi Lin, H. Murakami, Makoto Nishio, Luis Paz-Ares, F. Cantero, C. Gabarroca, E. Gandossi, N. Kamsu-Kom, S. Pennaforte, M.-. Secouard-Faure, Keunchil Park
- Abstract
Loading...
-
+
MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches
- 15:45 - 17:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:K. Shibuya, Francoise Mornex
-
+
MA 16.04 - Phase II Trial of S-1 Treatment as Palliative-Intent Chemotherapy for Previously Treated Advanced Thymic Carcinoma
16:00 - 16:05 | Presenter: Fumiyoshi Ohyanagi | Author(s): Y. Okuma, Yasushi Goto, K. Sunami, Y. Nakahara, S. Kitazono, Y. Tambo, N. Yanagitani, Shintaro Kanda, A. Horiike, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, Makoto Nishio, Yuichiro Ohe, Y. Hosomi
- Abstract
Loading...
-
+
MA 17 - Locally Advanced NSCLC
- 15:45 - 17:30
- 10/17/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Oral
- Track: Locally Advanced NSCLC
- Moderators:S. Jheon, Georgios Stamatis
-
+
MA 17.06 - Safety Data from Randomized Phase II Study of CDDP+S-1 vs CDDP+PEM Combined with TRT for Locally Advanced Non-Squamous NSCLC
16:20 - 16:25 | Presenter: Akira Ono | Author(s): T. Takahashi, Seiji Niho, T. Yoshida, T. Akimoto, K. Sakamaki, Takashi Seto, Makoto Nishio, N. Yamamoto, T. Hida, Hiroaki Okamoto, T. Kurata, Miyako Satouchi, Koichi Goto, T. Yamanaka, Yuichiro Ohe
- Abstract
Loading...